Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study.
- DOI
- 10.1186/s10194-024-01721-6
- Published
- 2024 Feb 2
- Container
- The journal of headache and pain
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10194-024-01721-6,
title = {Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study.},
author = {Grazzi L and Giossi R and Montisano DA and Canella M and Marcosano M and Altamura C and Vernieri F},
year = {2024},
journal = {The journal of headache and pain},
doi = {10.1186/s10194-024-01721-6},
url = {https://doi.org/10.1186/s10194-024-01721-6}
}RIS
TY - JOUR TI - Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study. AU - Grazzi L AU - Giossi R AU - Montisano DA AU - Canella M AU - Marcosano M AU - Altamura C AU - Vernieri F PY - 2024 JO - The journal of headache and pain DO - 10.1186/s10194-024-01721-6 UR - https://doi.org/10.1186/s10194-024-01721-6 ER -
APA
L, G., R, G., DA, M., M, C., M, M., C, A., & F, V. (2024). Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study.. The journal of headache and pain. https://doi.org/10.1186/s10194-024-01721-6
Source records
- pubmed · retrieved 2026-09-27T08:42:09.235Z